Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Pekrun

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
JCI Insight|November 15, 2019
Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectorsKatja Pekrun, Gustavo De Alencastro, Qing-Jun Luo, et al.
Molecular Therapy. Methods & Clinical Development|September 4, 2023
Selection of viral capsids and promoters affects the efficacy of rescue of <i>Tmprss3</i>-deficient cochleaKsenia A Aaron, Katja Pekrun, Patrick J Atkinson, et al.
Frontiers in Immunology|May 8, 2023
A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectorsMeredith E Davis-Gardner, Jesse A Weber, Jun Xie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2021
Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase ComplexGustavo de Alencastro, Francesco Puzzo, Mara Pavel-Dinu, et al.
Nature Biotechnology|April 8, 2024
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectorsFabian P Suchy, Daiki Karigane, Yusuke Nakauchi, et al.
Molecular Therapy. Methods & Clinical Development|August 14, 2018
Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal MuscleNicole K Paulk, Katja Pekrun, Gregory W Charville, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral SeroreactivityNicole K Paulk, Katja Pekrun, Erhua Zhu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
JCI Insight|November 15, 2019
Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectorsKatja Pekrun, Gustavo De Alencastro, Qing-Jun Luo, et al.
Molecular Therapy. Methods & Clinical Development|September 4, 2023
Selection of viral capsids and promoters affects the efficacy of rescue of <i>Tmprss3</i>-deficient cochleaKsenia A Aaron, Katja Pekrun, Patrick J Atkinson, et al.
Frontiers in Immunology|May 8, 2023
A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectorsMeredith E Davis-Gardner, Jesse A Weber, Jun Xie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2021
Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase ComplexGustavo de Alencastro, Francesco Puzzo, Mara Pavel-Dinu, et al.
Nature Biotechnology|April 8, 2024
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectorsFabian P Suchy, Daiki Karigane, Yusuke Nakauchi, et al.
Molecular Therapy. Methods & Clinical Development|August 14, 2018
Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal MuscleNicole K Paulk, Katja Pekrun, Gregory W Charville, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral SeroreactivityNicole K Paulk, Katja Pekrun, Erhua Zhu, et al.
Pageof 2